Thu, October 27, 2011
Wed, October 26, 2011
Tue, October 25, 2011
Mon, October 24, 2011
[ Mon, Oct 24th 2011 ] - Market Wire
Cigna to Acquire HealthSpring
Sat, October 22, 2011
Fri, October 21, 2011
Thu, October 20, 2011
Wed, October 19, 2011
Tue, October 18, 2011
Mon, October 17, 2011
Sun, October 16, 2011
Sat, October 15, 2011
Fri, October 14, 2011
Thu, October 13, 2011
Wed, October 12, 2011
[ Wed, Oct 12th 2011 ] - Market Wire
Financial Statement 10/11

Dendreon Announces Webcast Presentations at Upcoming Conferences


//health-fitness.news-articles.net/content/2011/ .. bcast-presentations-at-upcoming-conferences.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


SEATTLE--([ BUSINESS WIRE ])--Dendreon Corporation (Nasdaq:DNDN) today announced that management will present at the following conferences:

  • Credit Suisse Healthcare Conference in Phoenix, Arizona on November 9, 2011 at 8:00 a.m. MT
  • Lazard Healthcare Conference in New York City, NY on November 15, 2011 at 9:00 a.m. ET

The presentations will be webcast live and available for replay from Dendreon's website, [ www.dendreon.com ]. If you are unable to listen to the live webcasts, they will be archived on the site following the presentation. To access the replay, go to the Investor Relations section of the website.

About Dendreon

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development, commercialization and manufacturing of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response in a variety of tumor types. Dendreon's first product, PROVENGE®, was approved by the FDA in April 2010. Dendreon is exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. The Company is headquartered in Seattle, Washington and is traded on the NASDAQ Global Market under the symbol DNDN. For more information about the Company and its programs, visit [ http://www.dendreon.com/ ].


Publication Contributing Sources